Zicron-Ya'acov, Israel

Naftaly Sharir


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naftaly Sharir: Innovator in Medical Device Security

Introduction

Naftaly Sharir is a notable inventor based in Zicron-Ya'acov, Israel. He has made significant contributions to the field of medical devices, particularly in enhancing the security of implanted systems. His innovative approach addresses critical vulnerabilities associated with the control of medical implants.

Latest Patents

Sharir holds a patent for a groundbreaking invention titled "Safe control of implants and other devices using ultrasound communication." This patent focuses on medical devices implanted in human bodies, which are often susceptible to tampering and interference. His invention proposes a solution where implanted systems can be controlled exclusively through ultrasound signals or can only respond to RF commands after being unlocked by a specific ultrasound signal. This method significantly enhances the security of these devices, as ultrasound waves can only penetrate the body when the transmitter is in direct contact.

Career Highlights

Naftaly Sharir has dedicated his career to advancing medical technology. His work at Terafence Ltd. has positioned him as a key player in the development of secure medical devices. His innovative solutions have the potential to improve patient safety and device reliability.

Collaborations

Sharir collaborates with Yoram Palti, contributing to the advancement of medical technology through their combined expertise.

Conclusion

Naftaly Sharir's contributions to the field of medical devices exemplify the importance of innovation in enhancing security and functionality. His patented technology represents a significant step forward in protecting patients and ensuring the integrity of implanted systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…